Recruiting
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
NCT07604571
- Conditions
- Advanced HR+/HER2- Breast Cancer
- Locations
-
- Mary Crowley Cancer Research Dallas, Texas, United States
- Novartis Investigative Site Hirakata, Osaka, Japan
- Novartis Investigative Site Singapore
- Yale New Haven Hospital New Haven, Connecticut, United States